A new study at the Montreal Neurological Institute at McGill University identifies a key mechanism for the normal development of motor nerve cells (motor neurons) - cells that control muscles. This finding is crucial to understanding and treating a range of conditions involving nerve cell loss or damage, from spinal cord injury to neurodegenerative diseases such as ALS, also known as Lou Gehrig's disease.
Nerve cell regeneration is a complex process. Not only do nerve cells have to regenerate, but just as importantly, their specific and individual connections need to be regenerated also. The study, published recently in the Proceedings of the National Academy of Sciences, provides invaluable insight into these vital processes by understanding the mechanisms involved in normal development of selected types of spinal cord motor nerve cells.
Motor neurons are highly specialized. They have distinct characteristics and connect to specific muscle types in specific regions of the body. "These highly targeted nerve cell-to-muscle connections are determined in part by specific patterns of gene expression during embryonic development. More specifically, certain genes are expressed which tell the neuron what its properties will be, where to settle and which particular muscle to connect with," says Dr. Stefano Stifani, neuroscientist at the Montreal Neurological Institute and lead investigator in the study.
When nerve cells develop they require characteristic patterns of gene expression in order to become motor neurons or another type of nerve cell called interneurons. Dr. Stifani and colleagues show that during development, motor nerve cells have to express certain genes that continually suppress interneuron developmental characteristics.
"We have identified a key factor, called Runx1, which controls the correct development of motor neurons in the upper part of the spinal cord. Runx1, a factor that controls gene expression, helps motor neurons to maintain their status by regulating the expression of specific genes. In doing so, it might also help motor neurons find their target muscles."
Understanding the normal development and the highly specialized nature of nerve cells has important implications for understanding diseased or damaged nerve cells. For example, in ALS, the motor nerve cells that are involved in swallowing and controlling the tongue are often the first to degenerate. Knowing the specific patterns of gene expression of different motor nerve cells may help to explain why certain motor neurons are more susceptible to degeneration and help identify new targets for treatments.
Source: Montreal Neurological Institute and Hospital
Related stories:
Data mining detects signs of Lou Gehrig's disease in gene carriers long before symptoms appear
Inspired by the use of microarray chips that look for gene combinations, psychologists are using "pattern array" software to spot movements in rats that might help them predict diseases such as Lou Gehrig's syndrome.
Neurons created from skin cells of elderly ALS patients
Less than 27 months after announcing that he had institutional permission to attempt the creation of patient and disease-specific stem cell lines, Harvard Stem Cell Institute (HSCI) Principal Faculty member Kevin Eggan today proclaimed the effort a success - though politically imposed restrictions and scientific advances prompted him to use a different technique than originally planned.
Protein plays Jekyll and Hyde role in Lou Gehrig's disease
Amyotrophic lateral sclerosis (ALS), more commonly known as Lou Gehrig's disease, is a fatal neurodegenerative disease caused by the death of motor neurons in the brain and spinal cord that control muscle movements from walking and swallowing to breathing. In a groundbreaking study this week in
PLoS Biology, Brandeis and Harvard Medical School scientists report key findings about the cause and occurrence of the familial form of ALS.
Lou Gehrig's protein found throughout brain, suggesting effects beyond motor neurons
Two years ago researchers at the University of Pennsylvania School of Medicine discovered that misfolded proteins called TDP-43 accumulated in the motor areas of the brains of patients with amyotropic lateral sclerosis (ALS), or Lou Gehrig's disease. Now, the same group has shown that TDP-43 accumulates throughout the brain, suggesting ALS has broader neurological effects than previously appreciated and treatments need to take into account more than motor neuron areas. Their article appeared in last month's issue of the
Archives of Neurology.
On the evolutionary trail of molecules that cause Lou Gehrig's disease
What became a scientific quest for Dr. Hugo Bellen and his colleagues at Baylor College of Medicine in Houston began with trying to define the function of a protein that plays a role in the nervous system.
Mixing and matching genes to keep nerve cells straight
With fewer than 30,000 human genes with which to work, Nature has to mix and match to generate the myriad types of neurons or nerve cells needed to assemble the brain and nervous system. Keeping this involved process on the straight and narrow requires a clever balance of promotion and inhibition, said researchers from Baylor College of Medicine in Houston in a report that appears in the current edition of the journal
Developmental Cell.
New research shows risk of ALS exposure in Gulf War veterans is time limited
A new study, led by researchers at the University of Cincinnati (UC), says that cases of Amyotrophic Lateral Sclerosis (ALS) among soldiers who served in the first Persian Gulf War were caused by certain events during their deployment to the war zone, meaning the exposure and illness is not as widespread as previously thought. The study is being published in the July issue of
Neuroepidemiology.
Researchers gain new insights on spinal muscular atrophy
Researchers from the University of Pennsylvania School of Medicine discovered that the effect of a protein deficiency, which is the basis of the neuromuscular disease spinal muscular atrophy (SMA), is not restricted to motor nerve cells, suggesting that SMA is a more general disorder. This new insight will allow for better understanding of how this complex disease arises. Gideon Dreyfuss, PhD, the Isaac Norris Professor of Biochemistry and Biophysics and Investigator, Howard Hughes Medical Institute and colleagues, report their findings in last week's issue of
Cell.